Seventy‐four children (aged 1–7 years, type 1 diabetes duration ≥6 months, insulin pump use ≥3 months) were randomized to use either a hybrid closed‐loop system (intervention) or sensor‐augmented pump therapy (control) for 16 weeks. Here, INS is linked to type 1 diabetes mellitus.